Avitar, Inc. (AVTI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
United States Steel Market Cap
Avitar has a market cap or net worth of $731.00 as of August 1, 2025. Its market cap has decreased by -99.50% in one year.
Market Cap
731.00
Enterprise Value
n/a
Revenue
2.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 11, 1992, Avitar's market cap has decreased from 11.60M to 731.00, a decrease of -99.99%. That is a compound annual growth rate of -25.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2025 | 731.00 | - |
| Dec 31, 2024 | 731.00 | - |
| Dec 19, 2023 | 731.00 | - |
| Dec 30, 2021 | 731.00 | -99.74% |
| Dec 31, 2020 | 285.21K | 30.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 435.01M |
| Northwest Biotherapeutics | 372.10M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 341.59M |